Avalyn Pharma, Inc. (AVLN)
37.39
+1.95
(+5.50%)
USD |
NASDAQ |
Sep 04, 16:00
37.00
-0.39
(-1.04%)
After-Hours: 20:00
Avalyn Pharma Price to Book Value : 4.161 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 4.161 |
| September 03, 2026 | 3.944 |
| September 02, 2026 | 3.960 |
| September 01, 2026 | 3.926 |
| August 31, 2026 | 3.865 |
| August 28, 2026 | 3.861 |
| August 27, 2026 | 4.063 |
| August 26, 2026 | 4.122 |
| August 25, 2026 | 4.251 |
| August 24, 2026 | 4.195 |
| August 21, 2026 | 4.270 |
| August 20, 2026 | 4.132 |
| August 19, 2026 | 4.337 |
| August 18, 2026 | 4.325 |
| August 17, 2026 | 4.257 |
| August 14, 2026 | 4.368 |
| August 13, 2026 | 4.071 |
| August 12, 2026 | 4.160 |
| August 11, 2026 | 3.946 |
| August 10, 2026 | 3.846 |
| August 07, 2026 | 3.775 |
| August 06, 2026 | 3.639 |
| August 05, 2026 | 3.561 |
| August 04, 2026 | 3.42 |
| Date | Value |
|---|---|
| August 03, 2026 | 3.172 |
| July 31, 2026 | 3.204 |
| July 30, 2026 | 3.262 |
| July 29, 2026 | 3.127 |
| July 28, 2026 | 3.093 |
| July 27, 2026 | 3.074 |
| July 24, 2026 | 3.111 |
| July 23, 2026 | 3.309 |
| July 22, 2026 | 3.196 |
| July 21, 2026 | 3.231 |
| July 20, 2026 | 3.186 |
| July 17, 2026 | 3.150 |
| July 16, 2026 | 2.858 |
| July 15, 2026 | 3.049 |
| July 14, 2026 | 3.147 |
| July 13, 2026 | 3.098 |
| July 10, 2026 | 3.123 |
| July 09, 2026 | 3.219 |
| July 08, 2026 | 3.221 |
| July 07, 2026 | 3.163 |
| July 06, 2026 | 3.077 |
| July 02, 2026 | 3.309 |
| July 01, 2026 | 3.358 |
| June 30, 2026 | 3.664 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.6228 |
| CorMedix, Inc. | 1.421 |
| Eloxx Pharmaceuticals, Inc. | 1.304 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 4.474 |
Price to Book Value Related Metrics
| Price | 37.39 |
| Earnings Yield | -5.64% |
| Market Cap | 1.658B |